Your fact-checks will appear here
Current treatments and medications for Alzheimer's disease, including their effects, risks, and FDA approval status.
Two categories of reliable, FDA‑approved treatments exist for Alzheimer’s disease today: longstanding symptomatic therapies that can modestly improve cognition or behavior, and a new class of anti‑amy...
Proven treatments for Alzheimer’s disease fall into two camps: modest symptomatic drugs that have been used for decades (cholinesterase inhibitors and memantine) and newer anti-amyloid immunotherapies...
Current ‑approved treatments for fall into two broad groups: long-standing symptom‑relief drugs (cholinesterase inhibitors and memantine) and newer disease‑modifying anti‑amyloid monoclonal antibodies...
There is no evidence in the provided reporting that any regulator‑approved supplement can modify the biological progression of frontotemporal dementia (FTD); multiple clinical reviews and advocacy gro...
Two families of peer‑reviewed, routinely cited treatments exist today: symptomatic agents (cholinesterase inhibitors and memantine) that modestly improve cognition or behavior, and more recently devel...
The FDA now recognizes two classes of treatments for Alzheimer’s: disease‑modifying, amyloid‑targeting monoclonal antibodies that can modestly slow clinical decline in early disease, and older symptom...